LYRM7 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.283800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.949400E-01
Normal-vs-Stage2
3.807400E-01
Normal-vs-Stage3
1.207010E-01
Normal-vs-Stage4
5.236400E-01
Stage1-vs-Stage2
2.613700E-02
Stage1-vs-Stage3
2.781600E-02
Stage1-vs-Stage4
5.977800E-01
Stage2-vs-Stage3
1.977400E-01
Stage2-vs-Stage4
2.339200E-01
Stage3-vs-Stage4
3.509900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.452380E-01
Normal-vs-AfricanAmerican
3.291800E-01
Normal-vs-Asian
2.815600E-01
Caucasian-vs-AfricanAmerican
9.038200E-01
Caucasian-vs-Asian
1.223410E-01
AfricanAmerican-vs-Asian
1.538430E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.261030E-01
Normal-vs-Female
1.572210E-01
Male-vs-Female
8.113400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
6.408000E-01
Normal-vs-Age(41-60Yrs)
2.794200E-01
Normal-vs-Age(61-80Yrs)
9.924300E-02
Normal-vs-Age(81-100Yrs)
3.758400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
7.712800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.566400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.156800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.637360E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.393590E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.551400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.309000E-01
Normal-vs-Daily Drinker
9.988200E-02
Normal-vs-Weekly Drinker
3.205600E-01
Normal-vs-Occasional Drinker
4.732000E-01
Normal-vs-Social Drinker
6.484400E-01
Non Drinker-vs-Daily Drinker
4.019000E-01
Non Drinker-vs-Weekly Drinker
8.465200E-01
Non Drinker-vs-Occasional Drinker
1.113210E-01
Non Drinker-vs-Social Drinker
1.144620E-01
Daily Drinker-vs-Weekly Drinker
3.566800E-01
Daily Drinker-vs-Occasional Drinker
2.828000E-01
Daily Drinker-vs-Social Drinker
2.482000E-01
Weekly Drinker-vs-Occasional Drinker
9.598300E-02
Weekly Drinker-vs-Social Drinker
1.018990E-01
Occasional Drinker-vs-Social Drinker
7.624600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.118600E-01
Normal-vs-Grade 2
5.128000E-02
Normal-vs-Grade 3
7.078400E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.130810E-01
Grade 1-vs-Grade 3
7.563800E-02
Grade 1-vs-Grade 4
2.118600E-01
Grade 2-vs-Grade 3
5.517000E-01
Grade 2-vs-Grade 4
5.128000E-02
Grade 3-vs-Grade 4
7.078400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.349900E-02
Normal-vs-NonDiabetic
1.465020E-01
Diabetic-vs-NonDiabetic
6.171200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.797000E-01
Normal-vs-NoPancreatitis
1.458790E-01
Pancreatitis-vs-NoPancreatitis
2.699700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.166400E-01
Normal-vs-N1
3.768400E-01
N0-vs-N1
6.888500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.803400E-01
Normal-vs-TP53-NonMutant
5.777400E-01
TP53-Mutant-vs-TP53-NonMutant
4.404200E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
